Alkermes
NasdaqGS:ALKS
$ 44,36
+ $0,07 (0,16%)
44,36 $
+$0,07 (0,16%)
End-of-day quote: 06/15/2026

Company Info

EPS Growth 5Y
37,33%
Revenue growth 5Y
6,31%
Price growth 5Y
79,46%
Market Cap
$7,38 B
Long-Term Debt
$0,29 B
Quarterly earnings
07/27/2026
Dividend
$0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number

Alkermes Price Chart (USD)

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
20,76%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
-57,15%
Outlook 12/26
W
-49,40%
Margin of safety
T
1,44%
Analyst Price Target
H
UP
50-week EMA Trend

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$45,00
1.44%
1.44
Last Update: 06/10/2026
Analysts: 17

Highest Price Target $59,00

Average Price Target $45,00

Lowest Price Target $34,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Alkermes
NasdaqGS:ALKS
80,98% 79,46% 1,52% 20,76% 5/6 -57,15% -49,40% 1,44% UP

Financials

Profile

Competitors

News

×